JPRN-UMIN000001384已完成2 期
Randomized Controlled Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma - ACE 500 Study
ACE 500 Study Group0 个研究点目标入组 450 人开始时间: 2008年10月14日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 450
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Subject has extra hepatic metastasis. 2. Tumor thrombosis exists at main portal vein. 3. Remarkable artery-portal vein shunt or veno-arterial shunt. 4. Uncontrollable ascites or pleural effusion. 5. History of severe hypersensitivity. 6. Any previous TACE or TAE for HCC. 7. Any previous chemotherapy using epirubicin or CDDP. 8. Complications as below (except chronic hepatitis or liver cirrhosis) 1) Severe heart disease 2) Myocardial infarction within 6 months 3) Renal insufficiency 4) Active infections (except virous hepatitis) 5) Gastrointestinal bleeding 6) Active double cancer 7) Hepatic encephalopathy or heavy mental disorder. 9.Pregnancy or lactation women, or women with suspected pregnancy or men with willing to get pregnant. 10. Any subject judged by the investigator to be unfit for any reason to participate in the study.
研究者
相似试验
招募中
不适用
A Randomized Clinical Trial of Transcatheter Arterial Infusion (TAI) appending to Radio Frequency Ablation Therapy for Hepatocellular CarcinomaHepatocellular CarcinomaJPRN-UMIN000008253Kyoundo Hospital90
已完成
不适用
A randomized controlled trial of transcatheter arterial chemoembolization(TACE) in patients with advanced hepatocellular:Comparison of periodical TACE versus recurrence time TACEadvanced hepatocellular carcinoma(HCC)JPRN-UMIN000000690Department of Clinical Research, National Hospital Organization Iwakuni Clinical Center78
已完成
不适用
Randomized control trial of transarterial chemoembolization with miriplatin-lipiodol suspension or drug eluting bead with doxorubicin for hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000013204Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Aichi, Japan56
招募中
3 期
Randomized controlled trial of percutaneous transesophageal gastric tubing (PTEG) in patients with gastrointestinal obstruction from cancer (JIVROSG-0805)Gastrointestinal obstruction from cancerJPRN-UMIN000003565Japan Interventional Radiology in Oncology Study Group (JIVROSG)40
已完成
1 期
A randomized controlled trial of intra-arterial infusion of CDDP for hepatocellular carcinoma to prevent intra-hepatic metastasis after curative resectioPatients after curative resection of hepatocellular carcinomaJPRN-UMIN000001138iigata Hepatocellular Carcinoma Therapy Study Group200